Journal of Global Infectious Diseases

EDITORIAL
Year
: 2017  |  Volume : 9  |  Issue : 3  |  Page : 91--92

State of globe: Biofilm formation in Staphylococcus aureus isolates


Mahsa Dastranj1, Abbas Farahani2, Saeed Shoja3, Gholamabbas Dinarvand4,  
1 Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz; Department of Microbiology, Kurdistan Science and Research Branch, Islamic Azad University, Sanandaj, Iran
2 Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
4 Department of Biochemistry, Faculty member of Abadan School of Medical Sciences, Abadan; Cancer Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Correspondence Address:
Abbas Farahani
Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Golestan St, Postal Code 67148-69914, Ahvaz
Iran




How to cite this article:
Dastranj M, Farahani A, Shoja S, Dinarvand G. State of globe: Biofilm formation in Staphylococcus aureus isolates.J Global Infect Dis 2017;9:91-92


How to cite this URL:
Dastranj M, Farahani A, Shoja S, Dinarvand G. State of globe: Biofilm formation in Staphylococcus aureus isolates. J Global Infect Dis [serial online] 2017 [cited 2017 Dec 14 ];9:91-92
Available from: http://www.jgid.org/text.asp?2017/9/3/91/212584


Full Text

Biofilms and their ability to stick to surfaces, in particular, pathogenic organisms that use this property for the onset of the disease are known as an important phenomenon. Biofilm formation by many bacteria gives the ability to cause severe infections.[1],[2] Biofilm formation is a main virulence determinant in infection by Staphylococcus aureus isolates.[3]S.aureus is a commensal that colonizes the skin, and mucous membranes of the human body and biofilm formation by S. aureus isolates have been found in human skin lesions.[4],[5]

Biofilm formation in S.aureus is usually considered as a four-step process of adherence, aggregation, maturation, and dispersal. Biofilm forming properties have been well described in the members of Staphylococcus spp., especially in S. aureus and Staphylococcus epidermidis.[6],[7] In many studies are discussed to biofilm formation and antibiotic resistance levels.[8] High levels of biofilm production have been observed in multidrug resistance organisms such as S.aureus isolates.[9],[10] Moreover, the incidence of multidrug-resistant S. aureus has increased in the hospital settings and community over the last decades and also most of them produce biofilm formation.[4],[11]

In certain unique clinical settings, the ability of the bacteria standardization may be quite important.[12],[13] The absence of any standardized method for concise description makes it difficult to compare the results from different laboratories. In the other hand, persistent infections are challenge for humans also deal with the spread of antibiotic resistance and treatment of these infections is more valuable.[1],[13],[14]

In final, these results from Singh, et al.[1] portend a strong dependence of biofilm formation in S. aureus and human diseases and also the biofilm production is well described in members of S. aureus. The results of this study showed that in vitro tissue culture plate assay can be standardized for biofilm formation in clinical isolates of S. aureus based on their biofilm-forming capacity. Identify biofilm-producing of S. aureus strains could be important. In fact, the development of biofilm is main factor of associated infections and drug resistance. S.aureus is one of the most important cause of nosocomial infections that biofilm formation is a most contribution to it, involved in many infections such as such as tooth decay, periodontitis, stye, carbuncle, impetigo, and pyoderma to persistent tissue infections such as wound infection, otitis media, osteomyelitis, rhinosinusitis, recurrent urinary tract infection, and endocarditis. Singh, et al.[1] showed strong and moderate biofilm forming isolates were found to be more resistant to commonly used antibiotics compared to nonbiofilm formers. Nevertheless, the correlation between the profile of antimicrobial drug resistance and biofilm production in other bacteria with delayed wound healing remains would be valuable.

References

1Singh AK, Prakash P, Achra A, Singh GP, Das A, Singh RK. Standardisation and classification of in vitro biofilm formation by clinical isolates of Staphylococcus aureus. J Glob Infect Dis 2017;9:93-101.
2Farahani A. State of globe: Enterococci: Virulence factors and biofilm formation. J Glob Infect Dis 2016;8:1-2.
3McCarthy H, Rudkin JK, Black NS, Gallagher L, O'Neill E, O'Gara JP. Methicillin resistance and the biofilm phenotype in Staphylococcus aureus. Front Cell Infect Microbiol 2015;5:1.
4Kwiecinski J, Kahlmeter G, Jin T. Biofilm formation by Staphylococcus aureus isolates from skin and soft tissue infections. Curr Microbiol 2015;70:698-703.
5Nourbakhsh F, Namvar AE. Detection of genes involved in biofilm formation in Staphylococcus aureus isolates. GMS Hyg Infect Control 2016;11:Doc07.
6Büttner H, Mack D, Rohde H. Structural basis of Staphylococcus epidermidis biofilm formation: Mechanisms and molecular interactions. Front Cell Infect Microbiol 2015;5:14.
7Fey PD, Olson ME. Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol 2010;5:917-33.
8Di Domenico EG, Farulla I, Prignano G, Gallo MT, Vespaziani M, Cavallo I, et al. Biofilm is a major virulence determinant in bacterial colonization of chronic skin ulcers independently from the multidrug resistant phenotype. Int J Mol Sci 2017;18. pii: E1077.
99. Trivedi U, Parameswaran S, Armstrong A, Burgueno-Vega D, Griswold J, Dissanaike S, Rumbaugh KP. Prevalence of Multiple Antibiotic Resistant Infections in Diabetic versus Nondiabetic Wounds. J Pathog. 2014;2014:173053.
10Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35 10 Suppl 2:S165-93.
11Torlak E, Korkut E, Uncu AT, Sener Y. Biofilm formation by Staphylococcus aureus isolates from a dental clinic in Konya, Turkey. J Infect Public Health 2017. pii: S1876-034130004-7.
12Pozzi C, Waters EM, Rudkin JK, Schaeffer CR, Lohan AJ, Tong P, et al. Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections. PLoS Pathog 2012;8:e1002626.
13Chen L, Wen YM. The role of bacterial biofilm in persistent infections and control strategies. Int J Oral Sci 2011;3:66-73.
14Waters EM, Rowe SE, O'Gara JP, Conlon BP. Convergence of Staphylococcus aureus persister and biofilm research: Can biofilms be defined as communities of adherent persister cells? PLoS Pathog 2016;12:e1006012.